MORGAM (an international pooling of cardiovascular cohorts).
about
Gender differences in genetic risk profiles for cardiovascular diseaseMaelstrom Research guidelines for rigorous retrospective data harmonizationThe Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project--design, population and data harmonization of a large-scale, international study.Combined effects of thrombosis pathway gene variants predict cardiovascular events.Italian network for obesity and cardiovascular disease surveillance: a pilot projectLack of association between polymorphisms of the IL18R1 and IL18RAP genes and cardiovascular risk: the MORGAM Project.Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study.Towards a molecular systems model of coronary artery diseaseAssociation of Adherence to a Healthy Diet with Cognitive Decline in European and American Older Adults: A Meta-Analysis within the CHANCES Consortium.Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countriesGenetic markers enhance coronary risk prediction in men: the MORGAM prospective cohortsRisk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies.Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø StudyAlcoholic Beverage Preference and Dietary Habits in Elderly across Europe: Analyses within the Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) Project.Case-cohort design in practice - experiences from the MORGAM ProjectIschemic stroke is associated with the ABO locus: the EuroCLOT studyThe impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts.A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.Prediction of risk of cardiovascular events in patients with mild to moderate coronary artery lesions using naïve Bayesian networks.Education and coronary heart disease: mendelian randomisation study.Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project.Biobanks for cardiovascular epidemiology and prevention.High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort.A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors.The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases.Epidemiology and prevention of cardiovascular disease: Quo vadis?Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: Implications for prevention.Educational class inequalities in the incidence of coronary heart disease in Europe.Twenty-Year Predictors of Peripheral Arterial Disease Compared With Coronary Heart Disease in the Scottish Heart Health Extended Cohort (SHHEC).Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.The contribution of educational class in improving accuracy of cardiovascular risk prediction across European regions: The MORGAM Project Cohort Component.A polymorphism in ACE2 is associated with a lower risk for fatal cardiovascular events in females: the MORGAM project.Evaluating whole genome amplification via multiply-primed rolling circle amplification for SNP genotyping of samples with low DNA yield.Frank Pantridge's Legacy: A Symposium.European health examination surveys – a tool for collecting objective information about the health of the population.
P2860
Q21092169-2B12D086-6AD5-4B81-91A9-EC303AF3F5EDQ30847112-A823A011-6AA4-42B7-9795-A90BF46537BBQ30878015-0D47E914-8507-4F95-B417-032458E03110Q33293167-8F3B3E56-C123-4091-B9C4-B8686535F115Q33372574-77AB9A0B-BF21-488F-8DA3-B60FA0729DAAQ33453963-03954CE8-7FFC-43B5-AA15-02CF2749F915Q33717049-F00FC283-FC17-4FC4-892B-1DD5E8011AA2Q33729494-8AE3E6E9-EB07-494B-AD56-2C1C24089D56Q33735187-DABED5A1-29D4-4F9D-AD19-8F78447B23C3Q33768940-FF44B0ED-6647-40E6-A0F1-271FA73DB64BQ34224453-6BBDC30D-0C32-47EA-9A9A-4248C7CD94E0Q34340697-3356FDCF-DD0A-4477-B35F-F80E5F3B778EQ34358091-6D4CA99E-D027-44BB-9DAC-39695EDC0A7CQ34598124-AD8AB4C0-2D25-44CA-8834-A43AA3470579Q34860519-AEA50EF6-F651-4051-B739-CF86EDA88FFCQ35877398-FD71705D-04BE-41C7-B8CB-9BB2BE7250D8Q36109073-95F4BFA6-79A8-46EE-A738-1C99E6DD6813Q36409742-FAF25290-54FF-47BC-8489-EFC8F97F08E6Q36637803-6A9A66EB-21FE-40F4-A067-4E7631CD6870Q37226746-484CDB50-5EA4-44AF-B873-11315F9581A0Q37568754-94F872F1-73C7-4A25-963B-7DBE854F62A2Q37597969-B13BB7E8-C179-4EF0-9B7F-7A57A7749E55Q38601754-AB6B1084-3893-47D0-AC95-15D745AFEF47Q38690186-4FC88E4C-FFD7-431E-A19F-3268E0B10E5CQ38948539-EFE7AF21-F909-4F51-8499-3AA03EA32820Q39204219-2F2D3BF5-FD1B-451B-B310-04F2E4BA312AQ39337183-2869CE56-9613-4BF4-834F-E3F1247017CBQ40062073-DD668F2C-66D9-41A4-86C4-B31D6190AD67Q40182769-13B61767-DD2F-4AE9-AC2E-C1E1F0947F5CQ40357791-D0976750-9757-439A-8AEA-3FBA74ED0A77Q40478612-8FCC8D38-A31E-4D10-BE78-E36ACE62ECF0Q40927114-E4B70701-65C2-464D-8FF8-31525C5BBBBEQ42373691-97389C3A-7233-4C08-A342-CAAC0059B401Q47644063-1698CB74-B89B-4A2C-BB88-69D06B00C550Q49028473-0BC36797-F378-4B75-A91B-C26F47E811DBQ51090110-E07F1CB0-01A2-469D-9821-36D83808C7BDQ51476274-9D6E6C17-88BF-4279-B713-587A9350D2B4Q52992571-D57CA7BB-0DB7-47AE-96A0-C846511AAB40Q55312855-C24B30FA-4919-407F-805A-74E506837635Q55513977-64599DE1-23E2-46CF-85D0-F8FC67EC0AFF
P2860
MORGAM (an international pooling of cardiovascular cohorts).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
MORGAM (an international pooling of cardiovascular cohorts).
@ast
MORGAM (an international pooling of cardiovascular cohorts).
@en
type
label
MORGAM (an international pooling of cardiovascular cohorts).
@ast
MORGAM (an international pooling of cardiovascular cohorts).
@en
prefLabel
MORGAM (an international pooling of cardiovascular cohorts).
@ast
MORGAM (an international pooling of cardiovascular cohorts).
@en
P2093
P50
P356
P1476
MORGAM (an international pooling of cardiovascular cohorts).
@en
P2093
Alun Evans
Denis Shields
François Cambien
Hugh Tunstall-Pedoe
Kjell Asplund
MORGAM Project
Sangita Kulathinal
P356
10.1093/IJE/DYH327
P577
2004-11-23T00:00:00Z